Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial (Q34379367)

1 August 2017

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial (English)

1 reference

1 August 2017

0 references

1 reference

1

1 reference

1 August 2017

Brisa Fernandes

6

0 references

Sue M Cotton

Sue M Cotton

3

0 references

Ashley I. Bush

Ashley I Bush

14

0 references

Flávio Kapczinski

5

Flavio Kapczinski

1 reference

1 August 2017

Clarissa Severino Gama

4

Clarissa S Gama

1 reference

1 August 2017

16

Gin S Malhi

1 reference

1 August 2017

2

Olivia M Dean

1 reference

1 August 2017

15

Seetal Dodd

1 reference

1 August 2017

7

Kristy Kohlmann

1 reference

1 August 2017

12

Ian Schapkaitz

1 reference

1 August 2017

8

Susan Jeavons

1 reference

1 August 2017

11

Christine Allwang

1 reference

1 August 2017

13

Heidi Cobb

1 reference

1 August 2017

10

Kirsteen Moss

1 reference

1 August 2017

Karen Hewitt

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

14 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

10

1 reference

1 August 2017

91

1 reference

https://scigraph.springernature.com/pub.10.1186/1741-7015-10-91

1 August 2017

0 references

cites work

Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

Is lithium in a class of its own? A brief profile of its clinical use.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

The role of lamotrigine in the management of bipolar disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

A typical mood stabilizers: a "typical role for atypical antipsychotics.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

Revising axis V for DSM-IV: a review of measures of social functioning

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

A rating scale for mania: reliability, validity and sensitivity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

A New Depression Scale Designed to be Sensitive to Change

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3482580

N-Acetylcysteine ameliorates lithium-induced renal failure in rats

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

Antidepressant-like effects of N-acetyl-L-cysteine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

Mitochondrial Dysfunction and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-91

The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22891797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22891797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22891797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1741-7015-10-91

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference